Squadron Capital Management Reports New 9.6% Stake in SCYNEXIS, Inc.

On April 8, 2026, Squadron Capital Management, LLC filed a Schedule 13G indicating a new substantial position in SCYNEXIS, Inc. (SCYX). The filing reveals that as of March 31, 2026, Squadron Master Fund LP, Squadron Capital Management, LLC, and its partners Matthew Sesterhenn and William Blank collectively hold 7,608,695 shares of common stock. This represents a 9.6% ownership stake in the company, based on 79,442,633 shares outstanding. The reporting entities share voting and dispositive power over the reported shares. Squadron Capital Management, LLC operates as an investment adviser to private funds, including the Squadron Master Fund LP. The filing includes a certification that the securities were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer. This initial disclosure marks a significant increase from a previously reported 0% position, establishing the Squadron entities as major shareholders in the New Jersey-based pharmaceutical company.